Search

The findings could pave the way toward more targeted treatments for the disease.

… Friday, May 27, 2022 A previously unknown subtype of hormone-resistant prostate cancer accounts for about 30% of all cases, according to a new study from a team of scientists at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine, published May 27, 2022, in the journal Science . The

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.

… Monday, December 30, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Arvin Dar Elected to the National Academy of Inventors 2024 Class of Fellows Arvin Dar Elected to the National Academy of Inventors 2024 Class of Fellows Arvin Dar, PhD , Benno

New research from Memorial Sloan Kettering highlighted in advance of the 50th Annual Meeting of the American Society of Clinical Oncology demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of advanced pigmented villonodular synovitis, a rare and debilitating joint disease.

… Wednesday, May 14, 2014 A novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis (PVNS), a rare neoplastic joint disorder, according to new phase I data from Memorial Sloan Kettering Cancer Center and other institutions highlighted to media today in advance

As America commemorates the 50th anniversary of the “War on Cancer,” MSK addresses the question “Where do we go from here?”

… Thursday, April 1, 2021 This year marks the 50th anniversary of the “War on Cancer,” launched when President Richard Nixon signed the National Cancer Act in 1971. As America commemorates the milestone, the question for the future is: “Where do we go from here?” At Memorial Sloan Kettering, the direction

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.

… Wednesday, March 23, 2022 Dr. Yelena Janjigian hugs MSK patient Cecilia Defoe Cecilia Defoe (left) with MSK oncologist Yelena Janjigian. Cecilia says of Dr. Janjigian, “She’s part of my extended family now. Everybody in my family knows her, including my mom and my sisters. She’s a gem.” Scroll right

Researchers at Memorial Sloan Kettering (MSK) report today in the New England Journal of Medicine that adult patients with acute lymphoblastic leukemia (ALL) who received chimeric antigen receptor (CAR) T cell therapy responded better if they had a small amount of disease at the time of the treatment. Compared with patients with a greater amount of disease, those in the low-disease category lived significantly longer and experienced fewer life-threatening side effects.  

… Wednesday, January 31, 2018 Researchers at Memorial Sloan Kettering (MSK) report today in the New England Journal of Medicine that adult patients with acute lymphoblastic leukemia (ALL) who received chimeric antigen receptor ( CAR ) T cell therapy responded better if they had a small amount of disease

Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center.

… Monday, March 16, 2026 You probably know that at age 45, people at average risk are advised to begin screening for colorectal cancer. And you may be aware of various screening methods, particularly colonoscopy and the widely advertised at-home test called Cologuard®. But many people have questions about

Obtenga información sobre los diferentes métodos de detección de cáncer colorrectal, incluso la prueba casera Cologuard, de una experta de Memorial Sloan Kettering Cancer Center.

… Monday, March 16, 2026 Usted probablemente sepa que, a partir de los 45 años de edad, se recomienda que las personas que corren riesgo promedio de padecer cáncer colorrectal comiencen a hacerse pruebas de detección de dicha enfermedad. También puede que conozca diversos métodos de diagnóstico, en particular

Узнайте о способах обследования на наличие рака толстой и прямой кишки, в том числе о домашнем анализе Cologuard, у специалиста Memorial Sloan Kettering Cancer Center.

… Monday, March 16, 2026 Возможно, вы знаете, что людям в возрасте от 45 лет со средним уровнем риска развития рака толстой и прямой кишки рекомендовано проходить обследования. Вам также может быть известно о различных способах такого обследования, в частности о колоноскопии и широко разрекламированном

Edward Athanasian discusses the unique challenges of operating on sarcomas and other tumors in the hand.

… Tuesday, July 24, 2018 Summary Edward Athanasian is the only surgeon in the United States who is trained in both surgical oncology and hand surgery. He is also Chief of the Hand and Upper Extremity Service at the Hospital for Special Surgery in New York City. Sarcoma is not one distinct cancer but more